Bone Pathology pp 285-345 | Cite as

The Surgical Pathology of Bone Tumors and Tumor-Like Lesions



Primary bone tumors, especially malignant ones, are rare and so unfamiliarity on a day-to-day basis with the various entities adds to the difficulty with their diagnosis and management within the entire clinical team including the surgeon, radiologist, pathologist, and internist or medical oncologist. This chapter takes an overview of the most important of the benign and malignant primary bone tumors. A section on differential diagnosis is included to help the surgical pathologist in diagnosis. This chapter emphasizes a good coordination with radiologists, clinicians, and pathologists to come to the correct diagnosis.


Unicameral bone cyst Aneurysmal bone cyst Synovial cyst Intraosseous ganglion Enostosis Osteoma Osteoid osteoma Osteoblastoma Osteosarcoma Periosteal osteosarcoma Parosteal osteosarcoma Secondary bone tumors Telangiectatic osteosarcoma  Chondroblastic Osteoblastic Fibroblastic Giant cell rich Low-grade intraosseous High-grade surface Neoadjuvantchemotherapy Small cell Osteochondroma Nora’s lesion Chondroma Chondroblastoma Chondromyxoid fibroma Chondrosarcoma Exostosis Enchondromatosis Ollier’s disease Clear cell chondrosarcoma Mesenchymal chondrosarcoma Dedifferentiated chondrosarcoma Hemangioma Angiomatosis Gorham’s disease Epitheloid hemangioendothelioma Angiosarcoma Hemangiopericytoma Solitary fibrous tumor Glomus tumor Giant cell tumor (GCT) Giant cell reparative granuloma Desmoplastic fibromaFibrosarcoma Benign fibrous histiocytoma Nonossifying fibroma (NOF) Malignant fibrous histiocytoma Fibrous dysplasia (FD) Osteofibrous dysplasia Adamantinoma Ewing’s sarcoma Intraosseous lipoma Intraosseous liposarcoma Leio- myosarcoma Intraosseous schwannoma Chordoma Chondroid chordoma Plasma cell myeloma Leukemia Granulocytic sarcoma Non-Hodgkin’s disease Hodgkin’s disease Langerhans cell histiocytosis (LCH) Erdheim-Chester disease 


  1. 1.
    Vayego SA, De Conti OJ, Varella-Garcia M. Complex cytogenetic rearrangement in a case of unicameral bone cyst. Cancer Genet Cytogenet 1996; 86:46–49.PubMedCrossRefGoogle Scholar
  2. 2.
    Struhl S, Edelson C, Pritzker H, et al. Solitary (unicameral) bone cyst. The fallen fragment sign revisited. Skeletal Radiol 1989; 18:261–5.PubMedCrossRefGoogle Scholar
  3. Malawer MM. The diagnosis, treatment and management of unicameral bone cysts by percutaneous aspiration, hemodynamic evaluation and intracavitary methylprednisolone acetate. Orth Surg Update Series Volume Four, Lesson 26, 1986 CPEC, New Jersey.Google Scholar
  4. 4.
    Panoutsakopoulos G, Pandis N, Kyriazoglou I, et al. Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer 1999; 26:265–266.PubMedCrossRefGoogle Scholar
  5. 5.
    Oliveira AM, Perez-Atayde AR, Inwards CY, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 2004; 165:1773–1780.PubMedCrossRefGoogle Scholar
  6. 6.
    Sanerkin NG, Mott MG, Roylance J. An unusual intraosseous lesion with fibroblastic, osteoclastic, osteoblastic, aneurysmal and fibromyxoid elements. “Solid” varient of aneurysmal bone cyst. Cancer 1983; 51:2278–2286.PubMedCrossRefGoogle Scholar
  7. 7.
    Baruffi MR, Volpon JB, Neto JB, Casartelli C. Osteoid osteomas with chromosome alterations involving 22q. Cancer Genet Cytogenet 2001; 124:127–131.PubMedCrossRefGoogle Scholar
  8. 8.
    Tuy BE, Obafemi AA, Beebe KS, Patterson FR. Case report: elevated serum Beta human chorionic gonadotropin in a woman with osteosarcoma. Clin Orthop Relat Res 2008 Apr; 466(4):997–1001.PubMedCrossRefGoogle Scholar
  9. 9.
    Miretti S, Roato I, Taulli R, Ponzetto C, Cilli M, Olivero M, Di Renzo MF, Godio L, Albini A, Buracco P, Ferracini R. A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging. PLoS ONE. 2008 Mar 19; 3(3):e1828.PubMedCrossRefGoogle Scholar
  10. 10.
    Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008 Mar; 134(3):281–297.PubMedCrossRefGoogle Scholar
  11. 11.
    Bacci G, Balladelli A, Forni C, Ferrari S, Longhi A, Benassi MS, Briccoli A, Serra M, Picci P. Adjuvant and neo-adjuvant chemotherapy for Ewing’s sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment. Ann Oncol. 2007 Dec; 18(12):2037–2040.PubMedCrossRefGoogle Scholar
  12. 12.
    Ellis JH, Siegel CL, Martel W, Weatherbee L, Dorfman HD. Radiologic features of well-differentiated osteosarcoma, 1988. AJR Am J Roentgenol 1988; 151:739–742.PubMedGoogle Scholar
  13. 13.
    Rose PS, Dickey ID, Wenger DE, et al Periosteal osteosarcoma: long-term outcome and risk of late recurrence. Clin Orthop Relat Res 2006 Dec; 453:314–317.PubMedCrossRefGoogle Scholar
  14. 14.
    Staals EL, Bacchini P, Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer2008 Apr 1; 112(7):1592–1599.PubMedCrossRefGoogle Scholar
  15. 15.
    Bordigoni P., Clement L., Turello R, et al. Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases. Bone Marrow Transplant 2002; 29:611–614.PubMedCrossRefGoogle Scholar
  16. 16.
    Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002; 30:306–310.PubMedCrossRefGoogle Scholar
  17. Swarts SJ, Neff JR, Hohansson SL et al. Significance of abnormalities of chromosome 5 and 8 in chondroblastoma. Clin Orthop 1998; 189–193.Google Scholar
  18. 18.
    Turcotte RE, Kurt A, Sim FH, Unni KK, McLeod RA. Chondroblastoma. Hum Pathol 1993; 24:944–949.PubMedCrossRefGoogle Scholar
  19. 19.
    Robinson LH, Unni KK, O’Laughlin S, Beabout JW, Siegal GP. Surface chondromyxoid fibroma of bone. Mod Pathol 1994; 7:10A.Google Scholar
  20. 20.
    Tallini G, Dorfman H, Brys P, et al Correlation between clinicopathological features and karyotype in 100 cartiliginous and chordoid tumors. A report from the chromosome and morphology (CHAMP) collaborative and study group. J Pathol 2002; 196:194–203.PubMedCrossRefGoogle Scholar
  21. 21.
    Ayala AG, Jae YR, Raymond AK. Bone tumors in Anderson’s pathology, 10th Edition. Ed. Damjanov I and Linder J. 1996. CV Mosby, St. Louis.Google Scholar
  22. 22.
    Naumann S, Krallman A, Unni K, et al Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol 2002; 15(5):572–576.PubMedCrossRefGoogle Scholar
  23. 23.
    Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (Tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol 1995; 26(6):587–593.PubMedCrossRefGoogle Scholar
  24. 24.
    Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH. Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop Relat Res 2007 Oct; 463:166–172.PubMedGoogle Scholar
  25. 25.
    Papagelopoulos PJ, Galanis EC, Mavrogenis AF, et al Survivorship analysis in patients with periosteal chondrosarcoma. Clin Orthop Relat Res 2006 Jul; 448:199–207.PubMedCrossRefGoogle Scholar
  26. 26.
    Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986; 122:684–687.PubMedCrossRefGoogle Scholar
  27. 27.
    Unni KK. Hemangioendothelioma and Hemangiopericytoma In Dahlin’s Bone Tumors. Raven-Lippincott, Philadelphia 1996.Google Scholar
  28. 28.
    Wold LE, Swee RG. Giant cell tumors of the hands and feet. Sem Diag Path 1984; 1:173–184.Google Scholar
  29. 29.
    Enneking WF. Musculoskeletal Tumor Surgery. Churchill Livingstone, New York: 1983, pp. 87–88.Google Scholar
  30. 30.
    Bridge JA, Swarts SJ, Buresh C, et al Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft-tissue and bone. Am J Pathol 1999; 154:729–733.PubMedCrossRefGoogle Scholar
  31. 31.
    Rosenberg AE, O’Connell JX, Dickersin GR, Bhan A. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol 1993; 24:284–293.PubMedCrossRefGoogle Scholar
  32. 32.
    Alman BA. Greel DA. Wolfe HJ. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 1996 Mar; 14(2):311–315.PubMedCrossRefGoogle Scholar
  33. 33.
    Campanacci M, Laus M. Osteofibrous dysplasia of the tibia and fibula J. Bone Jt. Surg 1981; 63A:367–275.Google Scholar
  34. 34.
    Sweet DE, Vinh TN, Devaney K. Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma. A clinicopathologic study of 30 cases. Am J Surg Pathol 1992; 16: 282–290.PubMedCrossRefGoogle Scholar
  35. 35.
    Dahlin DC, Berton F, Beabot JW, Campanacci M. Fibrocartilaginous mesenchymoma with low-grade malignancy. Skeletal Radiol 1984; 12:263–269.PubMedCrossRefGoogle Scholar
  36. 36.
    Unni KK. Adamantinoma of long bones: the mystery endures. Adv Anat Pathol 1996; 3(1):16–21.CrossRefGoogle Scholar
  37. 37.
    Czerniak B, Rojas-Corona RR, Dorfman H. Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer 1989; 64:2319–2334.PubMedCrossRefGoogle Scholar
  38. 38.
    Cavazzana AO, Miser JS, Jefferson J, Triche TJ. Experimental evidence for a neural origin of Ewing’s sarcoma of bone. Am J Pathol 1987; 127:507–518.PubMedGoogle Scholar
  39. 39.
    Bridge JA, Fidler ME, Neff, JR, et al Adamantinoma-like Ewing’s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol 1999 Feb; 23(2):159–165.PubMedCrossRefGoogle Scholar
  40. 40.
    Nascimento AG, Unni KK, Pritchard DJ, Cooper KL, Dahlin DC. A clinico-pathologic study of 20 cases of large-cell (atypical) Ewing’s sarcoma of bone. Am J Surg Path 1980; 4:29–36.PubMedCrossRefGoogle Scholar
  41. 41.
    Carney JA. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing’s syndrome. Am J Surg Pathol 1990; 14:206–22.PubMedCrossRefGoogle Scholar
  42. 42.
    Yamaguchi T, Yamato M, Saotome K. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions. Skeletal Radiol 2002; 31:413–418.PubMedCrossRefGoogle Scholar
  43. Vujovic S, Henderson S, Presneau N, Odell E, Jacques T, Tirabosco R, et al Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006.Google Scholar
  44. 44.
    Komp DM. Concepts in staging and clinical studies for treatment of Langerhans cell histiocytosis. Sem Oncol 1991; 18(1):18–23.Google Scholar
  45. 45.
    Orr FW, Sanchez-Sweatman OH, Kostenuik P, Singh G. Tumor-bone interaction in skeletal metastasis. Clin Orthop 1995; 312:19–33.PubMedGoogle Scholar
  46. 46.
    Khurana JS, Ogino S, Shen T, Parekh H, Scherbel U, Delong W, Feldman MD, Zhang PJ, Wolfe H, Alman BA. Bone Morphogenetic Proteins (BMPs) are expressed by both bone forming and non-bone forming lesions. Arch Pathol Lab Med 2004 Nov; 128(11):1267–1269.Google Scholar
  47. 47.
    Hipp JA, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of metastatic bone disease. Clin Orthop 1995; 312:120–135.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of PathologyTemple Univesity School of MedicinePhiladelphiaUSA

Personalised recommendations